Abstract
Traditional Chinese Medicine (TCM) is gaining prominence within Singapore’s predominantly Western medicine (WM) system, reflecting a broader shift towards integrative care. This commentary argues that education is the primary engine of TCM integration, with reforms in professional recognition, competency-based assessments, bilingual curricula, and structured clinical training aligning TCM with contemporary standards and enabling collaboration with WM. These educational advances have catalysed changes in clinical practice, most notably the incorporation of acupuncture into public healthcare institutions, and strengthened research through targeted funding, formal ethics oversight, and TCM–WM partnership. Despite progress, persistent barriers remain. Limited interprofessional education and communication impede collaborative care and fuel uncertainty about concurrent TCM–WM use. Financial constraints, including restricted subsidies, shape access and care-seeking for TCM. Safety concerns about Chinese proprietary medicines, including risks of adulteration, affect public and professional trust. Foundational differences in diagnostic frameworks and research methodologies complicate evaluation and standardisation, while patient non-disclosure of TCM use fragments care. Singapore’s experience illustrates that safe, evidence-informed TCM integration depends on sustained investment in interprofessional education, equitable financing, robust safety surveillance, and high-quality translational research. Advancing these priorities can support holistic, person‑centred care across both systems.

This publication has 10 references indexed in Scilit: